Loading…
← CockpitCompetitor Analysis › SETL.NS Standard Engineering Technology LtdOpen in the cockpit ↗

Standard Engineering Technology LtdSETL.NSCompetitor analysis, valuation and peers

India · INR·Pharma & Healthcare›Medical Specialties
Momentum leader 99
Mkt cap
$783M
US dollars, full cap
Free float
24%
of shares outstanding
$/day
$2.76M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-10.4 pp
WACC 20.0%
Hurdle
n/a
no reverse DCF
Close · INR₹366.45
1D+0.5%
1W+10.3%
1M+6.5%
3M+18.6%
6M+167.5%
YTD+143.8%
1Y+115.0%
ATR %5.2%
Beta1.01
52w lowhigh21.7% off high

What Standard Engineering Technology does

Employees: 905

Standard Engineering Technology at a glance

Size Standard Engineering Technology (SETL.NS) is an India Health Care company (Medical Specialties) with a market value of $783M, the 686th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹366.45 on 18 Nov 2026.

Performance Over six months the shares gained 167.5%, against -16.3% for the median peer and +3.8% for the India market (cap-weighted) — highest of 21 in its peer set.

Growth Revenue grew 45.3% over the last twelve months (peer median +10.2%); the operating margin is 13.8% (peer median 11.4%).

Valuation It trades at 7.7× enterprise value to sales against a peer median of 3.1× (3rd most expensive of 21).

Capital Return on invested capital runs 10.4 points below its cost of capital (20.0% WACC).

Relative performance

10020030021 May 202621 Aug 202618 Nov 2026SETL.NS 270Peer median 85
Six months, rebased to 100: Standard Engineering Technology against the median of its 20 peers (local-currency closes).

Standard Engineering Technology financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹9.63B₹7.74B₹6.14B₹5.44B₹4.98B
Revenue growth—+26%+13%+9%—
Gross profit₹2.47B₹1.49B₹1.27B₹1.08B₹968M
EBITDA₹1.52B₹1.21B₹1.09B₹963M₹861M
Net income₹917M₹800M₹643M₹584M₹534M
Free cash flown/a-₹54.7M-₹265M-₹1.07B-₹340M
Capital expendituren/a₹615M₹278M₹336M₹294M
Total debt₹1.83B₹807M₹658M₹1.27B₹780M

Quarterly statements and history in the cockpit →

Standard Engineering Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%+100%+150%-20%-10%0%+10%BBNXMLABCTKB1302VREX2190096530300463AMSMCAP688108688068688805300453603108KIDS301367SETL.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Standard Engineering Technology is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%2×4×6×8×BBNXMLABCTKB1302VREX2190096530300463MCAP688108688068688805002950300453603108INMDKIDS600855301367SETL.NSRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Standard Engineering Technology is the large dot.

Standard Engineering Technology competitors and peer comparison

How Standard Engineering Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Standard Engineering Technology against its 20 peers (data as of 18 Nov 2026)
MeasureSETL.NSPeer medianRank in peer set
1-month return+6.5%-6.7%4th highest of 21
6-month return+167.5%-16.3%highest of 21
Distance from 52-week high-21.7%-39.8%8th highest of 21
Revenue growth (TTM)+45.3%+10.2%highest of 21
Operating margin13.8%11.4%8th highest of 21
EV / Sales7.7×3.1×3rd most expensive of 21
ROIC minus cost of capital-10.4 pp-1.9 pp6th lowest of 21
EV / EBITDA48.9×13.1×most expensive of 9
Net debt / EBITDA0.1×0.3×5th least indebted of 10

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Standard Engineering Technology SETL.NSIndia$783M+168%+45%14%7.7×n/an/a
Beta Bionics BBNXUnited States$779M+42%+44%-73%4.3×n/an/a
Mesa Laboratories MLABUnited States$775M+33%+2%10%3.6×21.3%+13.2%
Cytek Biosciences CTKBUnited States$774M+57%+6%-21%2.6×n/an/a
LifeTech Scientific 1302.HKHong Kong$771M-30%+1%12%3.2×9.6%+15.5%
Varex Imaging VREXUnited States$771M+79%+5%8%1.2×n/an/a
Zylox-Tonbridge Medical Technology 2190.HKHong Kong$768M-16%+39%25%3.6×3.8%+105.8%
Seegene 096530.KSSouth Korea$808M-26%+13%13%1.2×-6.7%-15.9%
Maccura Biotechnology 300463.SZChina$756M-18%-1%-4%2.3×7.9%-10.2%
Advanced Medical Solutions AMS.LUnited Kingdom$811M+27%+6%12%3.0×20.0%+21.4%
MedCap MCAP.STSweden$811M-4%+17%15%3.6×2.7%+20.9%
Sino Medical Sciences Technology 688108.SSChina$753M-41%+22%19%7.8×27.9%+9.9%
Beijing Hotgen Biotech 688068.SSChina$815M-37%+8%-94%9.6×n/an/a
Ningbo Jansen Superconducting Technologies 688805.SSChina$818M-36%+36%16%6.8×35.6%+17.1%
Allmed Medical Products 002950.SZChina$747M-32%+14%8%1.5×n/an/a
Jiang Xi Sanxin Medtec 300453.SZChina$744M-3%+12%18%2.8×-1.9%+11.8%
Shanghai Runda Medical Technology 603108.SSChina$744M-36%-12%-2%1.7×20.3%-0.2%
InMode INMDUnited States$741M-8%+2%18%0.6×-10.8%+12.4%
OrthoPediatrics KIDSUnited States$826M+71%+16%-8%3.4×n/an/a
Beijing Aerospace Changfeng 600855.SSChina$738M-44%-10%-19%4.5×n/an/a
BMC Medical 301367.SZChina$737M-17%+37%17%1.8×-1.5%+15.6%

Questions

Which companies are Standard Engineering Technology's closest peers?
The cockpit's peer set: Beta Bionics (BBNX), Mesa Laboratories (MLAB), Cytek Biosciences (CTKB), LifeTech Scientific (1302.HK), Varex Imaging (VREX), Zylox-Tonbridge Medical Technology (2190.HK), Seegene (096530.KS), Maccura Biotechnology (300463.SZ).
Is Standard Engineering Technology expensive compared with its peers?
On ev / sales it trades at 7.7× against a peer median of 3.1×, 3rd most expensive of 21 in its peer set.
How has Standard Engineering Technology stock performed?
Over six months to 18 Nov 2026 the shares returned +167.5% against -16.3% for the median peer; over one year +115.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.